Buy, hold, sell: Qantas, Macquarie, Xero shares

Find out which of these ASX shares are tipped to storm 80% higher over the next 12 months.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Qantas Airways Ltd (ASX: QAN), Macquarie Group Ltd (ASX: MQG), and Xero Ltd (ASX: XRO) shares have all come under pressure at some point this year.

But what can we expect from the shares going forward?

Here's what the experts think.

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.

Image source: Getty Images

Buy Qantas shares

The ASX 200 airline shares were smashed lower earlier this year as conflict in the Middle East and rising fuel prices put airlines under pressure.

Jet fuel (refined from crude oil) is the highest operating cost for airlines. Given Australia imports more than 90% of its refined fuel, its local prices track global oil prices and currency movements. 

That means that when oil prices rise due to tight supply or geopolitical tensions, jet fuel prices also rise. This means that airlines, such as Qantas, face higher operating costs, which can pressure profits and potentially weigh on their share prices.

Despite the headwinds, Qantas shares staged an impressive comeback through June. Conflict in the Middle East has ramped up over the past couple of weeks, but this hasn't caused a share price crash, but rather a share price softening.

Robust domestic and international travel demand has helped the aviation giant's shares maintain some level of stability. And signs that inflation and cost-of-living is improving has also likely supported the stock.

It looks like Qantas shares could keep flying higher too. TradingView data shows the majority (12 out of 13) have a buy or strong buy rating on the shares. The $11.76 target price implies a potential 12% upside over the next 12 months, at the time of writing.

Buy Macquarie shares

Macquarie shares were the worst performers among ASX bank stocks in July. But the stock ended the month roughly flat. Through most of the year so far the ASX bank stock has performed strongly, rallying strongly in April and sitting close to an all-time high at the time of writing.

In July, the company had its AGM, posted its first-quarter FY27 update and announced that Shemara Wikramanayake will retire in November, with Greg Ward to take over the top job.

Macquarie described trading conditions during the first quarter as "satisfactory". Its Banking and Financial Services segment increased its profit contribution compared with the same period last year. Deposits rose by 4% during the quarter, while home loans grew by 6% and business banking loans increased by 3%.

The news was well-received by the market, and came off the back of the company's positive earnings result back in May. 

Brokers are still bullish on Macquarie's shares. TradingView data shows the majority (nine out of 15) have a buy or strong buy rating on the shares. However, the $262.77 target price implies a small 5% upside at the time of writing.

Buy Xero shares

Xero shares have nosedived over the past year, hitting a seven-year low of $61.58 in late July. At the time of writing, there has been around a 16% rebound from that dip, but it barely makes a dent in the amount of losses shed over the past 12 months. 

It's been a difficult year for the ASX 200 tech stock after a sector-wide sell-off saw its share price plunge. There were also concerns that some tech shares were trading above fair value after a sector-wide rally in late 2025.

But analysts haven't given up hope. And they all point to strong potential for share price growth for Xero going forward.

The company benefits from an incredibly sticky subscription base and high customer retention rates. This means its revenue is relatively predictable. 

As a relatively small market player, it also has a lot of growth potential. 

TradingView data shows that most analysts (13 out of 15) have a buy or strong buy rating on the shares. They tip an upside of around 80% to an average target price of $127.76, at the time of writing.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Cheerful businessman with a mining hat on the table sitting back with his arms behind his head while looking at his laptop's screen.
Broker Notes

Why Bell Potter just upgraded Fortescue shares

Let's see what the broker thinks of the mining giant.

Read more »

Devastated man with his head on his office desk with paperwork and a laptop.
ASX Share Market News

Which are the 10 most shorted ASX shares?

Short sellers have their eyes on these shares.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Broker Notes

Experts name 3 ASX shares to buy this week

Let's see which shares are being recommended this week.

Read more »

A man looking at his laptop and thinking.
ASX Share Market News

5 things to watch on the ASX 200 on Monday

It looks set to be a tough start to the week for Aussie investors.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
ASX Share Market News

ASX 200 technology and healthcare shares continued their comeback last week

ASX 200 tech stocks rose 8.2% and healthcare increased 5.5% over the week.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Male doctor in a lab coat working at laptop looking serious.
Broker Notes

Buy, hold, sell: What is Bell Potter saying about CSL shares?

Bell Potter has been looking at the biotech giant ahead of its results release.

Read more »

A bored woman looking at her computer, it's bad news.
Share Fallers

These were the worst-performing ASX 200 shares in July

These shares had a tough time in July. Let's find out why.

Read more »